HomeREGULATORY
REGULATORY

NIBIOHN to Promote Drug Discovery in Fields with Unmet Needs by Automating Target Discovery Using AI
(Aug.15.2017)

Dr Kondo (right) and Dr Mizuguchi
The National Institutes of Biomedical Innovation, Health and Nutrition’s (NIBIOHN) Center for Drug Design Research has begun building a system to promote drug discovery in fields with unmet medical needs such as intractable cancers, intractable diseases, and rare diseases using its artificial intelligence (AI)-based platform ...
(LOG IN FOR FULL STORY)

News Calendar